Chinese Journal of Dermatology ›› 2026, e20250537.doi: 10.35541/cjd.20250537
• Guidelines and Consensus • Previous Articles Next Articles
Chinese Society of Dermatology; China Dermatologist Association
Received:2025-09-28
Revised:2026-01-20
Online:2026-01-22
Published:2026-03-26
Contact:
Xiao Rong; Yang Bin; Gao Xinghua
CLC Number:
Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on the prevention, diagnosis, and treatment of nontuberculous mycobacterial skin infections associated with medical aesthetic procedures (2026 edition)[J]. Chinese Journal of Dermatology,2026,e20250537. doi:10.35541/cjd.20250537
| [1] | Tortoli E. Microbiological features and clinical relevance of new species of the genus Mycobacterium[J]. Clin Microbiol Rev, 2014,27(4):727⁃752. DOI: 10.1128/cmr.00035⁃14. |
| [2] | Johansen MD, Herrmann JL, Kremer L. Non⁃tuberculous mycobacteria and the rise of Mycobacterium abscessus[J]. Nat Rev Microbiol, 2020,18(7):392⁃407. DOI: 10.1038/s41579⁃020⁃0331⁃1. |
| [3] | Li Y, Zhang W, Zhao J, et al. Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes[J]. Emerg Microbes Infect, 2022,11(1):1973⁃1981. DOI: 10.1080/22221751. 2022.2103453. |
| [4] | Turenne CY. Nontuberculous mycobacteria: insights on taxonomy and evolution[J]. Infect Genet Evol, 2019,72:159⁃168. DOI: 10.1016/j.meegid.2019.01.017. |
| [5] | Ma X, Li XY, Liu JW. Demographic and clinical features of nontuberculous mycobacteria infection resulting from cosmetic procedures: a systematic review[J]. Int J Infect Dis, 2024,149:107259. DOI: 10.1016/j.ijid.2024.107259. |
| [6] | 中国疾病预防控制中心传染病预防控制所, 中国防痨协会人兽共患结核病专业分会. 分枝杆菌菌种中文译名专家共识[J]. 中国人兽共患病学报, 2023,39(3):205⁃220. DOI: 10. 3969/j.issn.1002⁃2694.2023.00.016. |
| [7] | Tortoli E, Fedrizzi T, Meehan CJ, et al. The new phylogeny of the genus Mycobacterium: the old and the news[J]. Infect Genet Evol, 2017,56:19⁃25. DOI: 10.1016/j.meegid.2017.10.013. |
| [8] | Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline[J]. Clin Infect Dis, 2020,71(4):e1⁃e36. DOI: 10.1093/cid/ciaa241. |
| [9] | Jabbour SF, Malek AE, Kechichian EG, et al. Nontuberculous mycobacterial infections after cosmetic procedures: a systematic review and management algorithm[J]. Dermatol Surg, 2020,46(1):116⁃121. DOI: 10.1097/dss.0000000000001929. |
| [10] | Zweijpfenning SMH, van Ingen J, Hoefsloot W. Geographic distribution of nontuberculous mycobacteria isolated from clinical specimens: a systematic review[J]. Semin Respir Crit Care Med, 2018,39(3):336⁃342. DOI: 10.1055/s⁃0038⁃1660864. |
| [11] | Ren H, Xiao Y, Tang B, et al. The price of beauty: a literature review on non⁃tuberculous mycobacteria infection after cosmetic procedures[J]. Aesthet Surg J, 2024,44(8):NP574⁃NP584. DOI: 10.1093/asj/sjae076. |
| [12] | Daniau C, Lecorche E, Mougari F, et al. Association of healthcare and aesthetic procedures with infections caused by nontuberculous mycobacteria, France, 2012-2020[J]. Emerg Infect Dis, 2022,28(3):518⁃526. DOI: 10.3201/eid2803.211791. |
| [13] | Wu UI, Holland SM. Host susceptibility to non⁃tuberculous mycobacterial infections[J]. Lancet Infect Dis, 2015,15(8):968⁃980. DOI: 10.1016/s1473⁃3099(15)00089⁃4. |
| [14] | Bernut A, Nguyen⁃Chi M, Halloum I, et al. Mycobacterium abscessus⁃induced granuloma formation is strictly dependent on TNF signaling and neutrophil trafficking[J]. PLoS Pathog, 2016,12(11):e1005986. DOI: 10.1371/journal.ppat.1005986. |
| [15] | Qiang L, Zhang Y, Lei Z, et al. A mycobacterial effector promotes ferroptosis⁃dependent pathogenicity and dissemination[J]. Nat Commun, 2023,14(1):1430. DOI: 10.1038/s41467⁃023⁃37148⁃x. |
| [16] | Pajuelo D, Tak U, Zhang L, et al. Toxin secretion and trafficking by Mycobacterium tuberculosis[J]. Nat Commun, 2021,12(1):6592. DOI: 10.1038/s41467⁃021⁃26925⁃1. |
| [17] | Kotey SK, Tan X, Fleming O, et al. Intracellular iron accumulation facilitates mycobacterial infection in old mouse macrophages[J]. Geroscience, 2024,46(2):2739⁃2754. DOI: 10. 1007/s11357⁃023⁃01048⁃1. |
| [18] | Yamamoto K, Torigoe S, Kobayashi H. Formative evaluation and structural analysis of non⁃tuberculosis mycobacterial biofilm using material pieces[J]. Cell Surf, 2024,11:100125. DOI: 10.1016/j.tcsw.2024.100125. |
| [19] | Stienstra Y, van der Graaf WT, te Meerman GJ, et al. Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors[J]. Trop Med Int Health, 2001,6(7):554⁃562. DOI: 10.1046/j.1365⁃3156.2001.00746.x. |
| [20] | Yeo PM, Lee SX, Tan YE, et al. Epidemiology, risk factors, and outcomes of adult cutaneous non⁃tuberculous mycobacterial infection over a 10⁃year period in Singapore[J]. Int J Dermatol, 2019,58(6):679⁃687. DOI: 10.1111/ijd.14356. |
| [21] | Perera DJ, Koger⁃Pease C, Paulini K, et al. Beyond schistosomiasis: unraveling co⁃infections and altered immunity[J]. Clin Microbiol Rev, 2024,37(1):e0009823. DOI: 10.1128/cmr.00098⁃23. |
| [22] | Mortaz E, Moloudizargari M, Varahram M, et al. What immunological defects predispose to non⁃tuberculosis mycobacterial infections?[J]. Iran J Allergy Asthma Immunol, 2018,17(2):100⁃109. |
| [23] | Sergeant A, Conaglen P, Laurenson IF, et al. Mycobacterium chelonae infection: a complication of tattooing[J]. Clin Exp Dermatol, 2013,38(2):140⁃142. DOI: 10.1111/j.1365⁃2230. 2012.04421.x. |
| [24] | Curcó N, Prat C, Tarroch X, et al. Cutaneous infection in a tattoo due to Mycobacterium chelonae: a report of 2 cases and a review of the literature[J]. Actas Dermosifiliogr, 2012,103(9):840⁃843. DOI: 10.1016/j.ad.2012.01.019. |
| [25] | Tan LC, Li XY, Lu YG. Nontuberculous mycobacteria infection after autologous fat grafting for cosmetic breast augmentation[J]. Ann Plast Surg, 2020,85(4):358⁃362. DOI: 10.1097/sap.000 0000000002234. |
| [26] | Green DA, Whittier S, Greendyke W, et al. Outbreak of rapidly growing nontuberculous mycobacteria among patients undergoing cosmetic surgery in the dominican republic[J]. Ann Plast Surg, 2017,78(1):17⁃21. DOI: 10.1097/sap.0000000000000746. |
| [27] | Saunders KE, Reyes JM, Cyril L, et al. Notes from the field: nontuberculous mycobacteria infections after cosmetic surgery procedures in Florida ⁃ nine states, 2022⁃2023[J]. MMWR Morb Mortal Wkly Rep, 2024,73(3):66⁃67. DOI: 10.15585/mmwr.mm7303a4. |
| [28] | Llenas⁃García J, Vicente J, Ruiz⁃García MM, et al. A "lipo⁃tourist" with chronic cutaneous lesions after surgery in Ecuador: a diagnostic challenge[J]. Travel Med Infect Dis, 2018,25:77⁃78. DOI: 10.1016/j.tmaid.2018.07.013. |
| [29] | E Y, Hengshu Z. Clinical analysis of nontuberculous mycobacterial infection after minimally invasive plastic surgery and cosmetic surgery[J]. J Cosmet Dermatol, 2022,21(6):2523⁃2529. DOI: 10.1111/jocd.14395. |
| [30] | 余敏, 廖桂秀, 纪明开. 美容注射术后皮肤脓肿分枝杆菌感染临床分析[J]. 中国麻风皮肤病杂志, 2022,38(1):37⁃38. DOI: 10.12144/zgmfskin202201037. |
| [31] | Deng L, Luo YZ, Liu F, et al. Subcutaneous infection caused by Mycobacterium abscessus following cosmetic injections of botulinum toxin: a case report[J]. World J Clin Cases, 2022,10(18):6141⁃6147. DOI: 10.12998/wjcc.v10.i18.6141. |
| [32] | Hammond SE, Al⁃Bayati A, Joumblat N, et al. Mycobacterium chelonae infection of the buttocks secondary to lipofilling: a case report and review of the literature[J]. Aesthetic Plast Surg, 2017,41(5):1150⁃1154. DOI: 10.1007/s00266⁃017⁃0890⁃3. |
| [33] | Culton DA, Lachiewicz AM, Miller BA, et al. Nontuberculous mycobacterial infection after fractionated CO₂ laser resurfacing[J]. Emerg Infect Dis, 2013,19(3):365⁃370. DOI: 10.3201/eid1903.120880. |
| [34] | Berliner JG, Aldabagh B, Mully T, et al. Non⁃tuberculous mycobacterial infections following cosmetic laser procedures: a case report and review of the literature[J]. J Drugs Dermatol, 2015,14(1):80⁃83. |
| [35] | Eustace K, Jolliffe V, Sahota A, et al. Cutaneous Mycobacterium abscessus infection following hair transplant[J]. Clin Exp Dermatol, 2016,41(7):768⁃770. DOI: 10.1111/ced.12900. |
| [36] | Grubbs J, Bowen C. Mycobacterium abscessus infection following home dermabrasion[J]. Cutis, 2019,104(1):79⁃80. DOI: Not available. |
| [37] | Yeon J, Chan RC, Fallah H. Infection with Mycobacterium immunogenum following botulinum toxin injection[J]. Australas J Dermatol, 2021,62(1):79⁃80. DOI: 10.1111/ajd.13406. |
| [38] | Pennington KM, Vu A, Challener D, et al. Approach to the diagnosis and treatment of non⁃tuberculous mycobacterial disease[J]. J Clin Tuberc Other Mycobact Dis, 2021,24:100244. DOI: 10.1016/j.jctube.2021.100244. |
| [39] | Cowman S, van Ingen J, Griffith DE, et al. Non⁃tuberculous mycobacterial pulmonary disease[J]. Eur Respir J, 2019,54(1):1900250. DOI: 10.1183/13993003.00250⁃2019. |
| [40] | van Ingen J, Turenne CY, Tortoli E, et al. A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review[J]. Int J Syst Evol Microbiol, 2018,68(11):3666⁃3677. DOI: 10.1099/ijsem.0.003026. |
| [41] | Yoshida M, Sano S, Chien JY, et al. A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibility[J]. EBioMedicine, 2021,64:103187. DOI: 10.1016/j.ebiom.2020.103187. |
| [42] | 中国防痨协会非结核分枝杆菌病分会. 非结核分枝杆菌病分子生物学诊断专家共识. 中国防痨杂志, 2025,47(8):961⁃975. DOI: 10.19982/j.issn.1000⁃6621.20250225 |
| [43] | Buckwalter SP, Olson SL, Connelly BJ, et al. Evaluation of matrix⁃assisted laser desorption ionization⁃time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes[J]. J Clin Microbiol, 2016,54(2):376⁃384. DOI: 10.1128/jcm.02128⁃15. |
| [44] | Huang WC, Yu MC, Huang YW. Identification and drug susceptibility testing for nontuberculous mycobacteria[J]. J Formos Med Assoc, 2020,119 (Suppl 1):S32⁃S41. DOI: 10.1016/j.jfma.2020.05.002. |
| [45] | Brown⁃Elliott BA, Woods GL. Antimycobacterial susceptibility testing of nontuberculous mycobacteria[J]. J Clin Microbiol, 2019,57(10):e00834⁃19. DOI: 10.1128/jcm.00834⁃19. |
| [46] | Komm OD, Almeida DV, Converse PJ, et al. In vitro assessment of drug activity against Mycobacterium ulcerans[J]. Methods Mol Biol, 2022,2387:189⁃194. DOI: 10.1007/978⁃1⁃0716⁃1779⁃3_18. |
| [47] | Raveendran R, Oberoi JK, Wattal C. Multidrug⁃resistant pulmonary & extrapulmonary tuberculosis: a 13 years retrospective hospital⁃based analysis[J]. Indian J Med Res, 2015,142(5):575⁃582. DOI: 10.4103/0971⁃5916.171285. |
| [48] | Sarro YD, Kone B, Diarra B, et al. Simultaneous diagnosis of tuberculous and non⁃tuberculous mycobacterial diseases: time for a better patient management[J]. Clin Microbiol Infect Dis, 2018,3(3):10.15761/CMID.1000144. DOI: 10.15761/cmid.100 0144. |
| [49] | Hendrikx L, van Hees CLM, de Steenwinkel JEM, et al. Treatment and outcome of culture⁃confirmed Mycobacterium marinum disease[J]. Open Forum Infect Dis, 2022,9(4):ofac077. DOI: 10.1093/ofid/ofac077. |
| [50] | Seidel A, Nunes DH, Fernandes C, et al. Skin infection by Mycobacterium marinum ⁃ diagnostic and therapeutic challenge[J]. An Bras Dermatol, 2022,97(3):366⁃368. DOI: 10.1016/j.abd.2021.03.013. |
| [51] | Griffith DE, Aksamit T, Brown⁃Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases[J]. Am J Respir Crit Care Med, 2007,175(4):367⁃416. DOI: 10.1164/rccm.200604⁃571ST. |
| [52] | Aubry A, Mougari F, Reibel F, et al. Mycobacterium marinum[J]. Microbiol Spectr, 2017,5(2):10.1128/microbiolspec.tnmi7⁃0038⁃2016. DOI: 10.1128/microbiolspec.TNMI7⁃0038⁃2016. |
| [53] | Bakuła Z, Modrzejewska M, Pennings L, et al. Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium kansasii[J]. Antimicrob Agents Chemother, 2018,62(4):e01788⁃17. DOI: 10.1128/aac.01788⁃17. |
| [54] | Zhang M, Feng M, He JQ. Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient[J]. Int J Infect Dis, 2017,62:59⁃63. DOI: 10.1016/j.ijid.2017. 07.006. |
| [55] | Moon SM, Choe J, Jhun BW, et al. Treatment with a macrolide⁃containing regimen for Mycobacterium kansasii pulmonary disease[J]. Respir Med, 2019,148:37⁃42. DOI: 10.1016/j.rmed.2019.01.012. |
| [56] | Lin S, Hua W, Wang S, et al. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates[J]. BMC Microbiol, 2022,22(1):175. DOI: 10.1186/s12866⁃022⁃02582⁃2. |
| [57] | Yao QH, Xia XJ, Xu JZ, et al. Primary cutaneous Mycobacteria avium complex infection in a systemic lupus erythematosus patient: a case report and review[J]. Medicine (Baltimore), 2025,104(6):e41450. DOI: 10.1097/md.0000000000041450. |
| [58] | Griffith DE, Eagle G, Thomson R, et al. Amikacin liposome inhalation suspension for treatment⁃refractory lung disease caused by Mycobacterium avium Complex (CONVERT). A prospective, open⁃label, randomized study[J]. Am J Respir Crit Care Med, 2018,198(12):1559⁃1569. DOI: 10.1164/rccm.201807⁃ 1318OC. |
| [59] | Saubolle MA, Kiehn TE, White MH, et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans[J]. Clin Microbiol Rev, 1996,9(4):435⁃447. DOI: 10.1128/cmr.9.4.435. |
| [60] | 王洪生, 陈符, 许高, 等. 皮肤嗜血分枝杆菌感染二例研究[J]. 中华皮肤科杂志, 2015,48(10):679⁃682. |
| [61] | Nookeu P, Angkasekwinai N, Foongladda S, et al. Clinical characteristics and treatment outcomes for patients infected with Mycobacterium haemophilum[J]. Emerg Infect Dis, 2019,25(9):1648⁃1652. DOI: 10.3201/eid2509.190430. |
| [62] | Wang XY, Jia QN, Li J. Treatment of non⁃tuberculosis mycobacteria skin infections[J]. Front Pharmacol, 2023,14:1242156. DOI: 10.3389/fphar.2023.1242156. |
| [63] | Chen Y, Jiang J, Jiang H, et al. Mycobacterium gordonae in patient with facial ulcers, nosebleeds, and positive T⁃SPOT.TB test, China[J]. Emerg Infect Dis, 2017,23(7):1204⁃1206. DOI: 10.3201/eid2307.162033. |
| [64] | Calado Nogueira de Moura V, Nguyen MH, Hunkins JJ, et al. In vitro susceptibility patterns for slowly growing non⁃tuberculous mycobacteria in the USA from 2018 to 2022[J]. J Antimicrob Chemother, 2023,78(12):2849⁃2858. DOI: 10.1093/jac/dkad317. |
| [65] | Kumar C, Shrivastava K, Singh A, et al. Skin and soft⁃tissue infections due to rapidly growing mycobacteria: an overview[J]. Int J Mycobacteriol, 2021,10(3):293⁃300. DOI: 10.4103/ijmy.ijmy_110_21. |
| [66] | Das S, Mishra B, Mohapatra PR, et al. Clinical presentations of nontuberculous mycobacteria as suspected and drug⁃resistant tuberculosis: experience from a tertiary care center in Eastern India[J]. Int J Mycobacteriol, 2022,11(2):167⁃174. DOI: 10. 4103/ijmy.ijmy_68_22. |
| [67] | Chung J, Ince D, Ford BA, et al. Cutaneous infections due to nontuberculosis Mycobacterium: recognition and management[J]. Am J Clin Dermatol, 2018,19(6):867⁃878. DOI: 10.1007/s40257⁃018⁃0382⁃5. |
| [68] | 中国"一带一路"皮肤病专病联盟分枝杆菌病研究联盟, 中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤非结核分枝杆菌病诊治专家共识(2024版)[J]. 中华皮肤科杂志, 2024,57(2):109⁃118. DOI: 10.35541/cjd.20230371. |
| [69] | Zhou J, Jia Q, Liu L, et al. Epidemiology and clinical outcomes in skin and soft tissue nontuberculous mycobacteria infections: a retrospective study[J]. J Infect Public Health, 2025,18(3):102655. DOI: 10.1016/j.jiph.2025.102655. |
| [70] | Nguyen TQ, Heo BE, Jeon S, et al. Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches[J]. Front Microbiol, 2024,15:1331508. DOI: 10.3389/fmicb.2024.1331508. |
| [71] | Tunesi S, Zelazny A, Awad Z, et al. Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra⁃pulmonary infections[J]. Clin Microbiol Infect, 2024,30(6):718⁃725. DOI: 10.1016/j.cmi.2023.09.019. |
| [72] | To K, Cao R, Yegiazaryan A, et al. General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus[J]. J Clin Med, 2020,9(8):2541. DOI: 10.3390/jcm9082541. |
| [73] | Leto Barone AA, Grzelak MJ, Frost C, et al. Atypical mycobacterial infections after plastic surgery procedures abroad: a multidisciplinary algorithm for diagnosis and treatment[J]. Ann Plast Surg, 2020,84(3):257⁃262. DOI: 10.1097/sap.0000 000000002061. |
| [74] | 郭晶东, 陈波, 彭靓, 等. 美容手术相关非结核分枝杆菌感染的诊断和治疗方法[J]. 中华烧伤与创面修复杂志, 2024,40(7):673⁃678. DOI: 10.3760/cma.j.cn501225⁃20231031⁃00160. |
| [75] | 李丹, 王羽, 林威, 等. 美容术后并发非结核分枝杆菌感染治疗策略[J]. 中国医疗美容, 2022,12(7):24⁃28. DOI: 10.19593/j.issn.2095⁃0721.2022.07.007. |
| [76] | Sartelli M, Coccolini F, Kluger Y, et al. WSES/GAIS/WSIS/SIS⁃E/AAST global clinical pathways for patients with skin and soft tissue infections[J]. World J Emerg Surg, 2022,17(1):3. DOI: 10.1186/s13017⁃022⁃00406⁃2. |
| [77] | McClain SL, Bohan JG, Stevens DL. Advances in the medical management of skin and soft tissue infections[J]. BMJ, 2016,355:i6004. DOI: 10.1136/bmj.i6004. |
| [78] | 张晗, 刘文辉, 李广帅. 注射溶脂致非结核分枝杆菌感染11例临床分析[J]. 中国美容医学, 2023,32(5):79⁃82. DOI: 10.15909/j.cnki.cn61⁃1347/r.005664. |
| [79] | Schwartzman G, Khachemoune A. Surgical site infection after dermatologic procedures: critical reassessment of risk factors and reappraisal of rates and causes[J]. Am J Clin Dermatol, 2021,22(4):503⁃510. DOI: 10.1007/s40257⁃021⁃00599⁃3. |
| [80] | Blanc P, Dutronc H, Peuchant O, et al. Nontuberculous mycobacterial infections in a French hospital: a 12⁃year retrospective study[J]. PLoS One, 2016,11(12):e0168290. DOI: 10.1371/journal.pone.0168290. |
| [81] | Henkle E, Hedberg K, Schafer SD, et al. Surveillance of extrapulmonary nontuberculous mycobacteria infections, Oregon, USA, 2007⁃2012[J]. Emerg Infect Dis, 2017,23(10):1627⁃1630. DOI: 10.3201/eid2310.170845. |
| [82] | Nelson R. The growing trend of medical tourism[J]. Am J Nurs, 2017,117(7):18⁃19. DOI: 10.1097/01.NAJ.0000520937.93481.b7. |
| [83] | Pavli A, Maltezou HC. Infectious complications related to medical tourism[J]. J Travel Med, 2021,28(1):taaa210. DOI: 10.1093/jtm/taaa210. |
| [84] | Pereira RT, Malone CM, Flaherty GT. Aesthetic journeys: a review of cosmetic surgery tourism[J]. J Travel Med, 2018,25(1):tay051. DOI: 10.1093/jtm/tay042. |
| [85] | World Health Organization. Global guidelines for the prevention of surgical site infection[R]. Geneva: World Health Organization, 2018. |
| [86] | National Institute for Health Research Global Research Health Unit on Global Surgery. Delphi prioritization and development of global surgery guidelines for the prevention of surgical⁃site infection[J]. Br J Surg, 2020,107(8):970⁃977. DOI: 10.1002/bjs.11530. |
| [87] | Ling ML, Apisarnthanarak A, Abbas A, et al. APSIC guidelines for the prevention of surgical site infections[J]. Antimicrob Resist Infect Control, 2019,8:174. DOI: 10.1186/s13756⁃019⁃0638⁃8. |
| [1] | Liu Lihao, Hu Yu, Chen Kun. Clinical application and development of photobiomodulation in dermatology [J]. Chinese Journal of Dermatology, 2026, 59(3): 278-282. |
| [2] | Wang Li, Wang Qianqiu, Zhang Ruili. Research progress in latent syphilis [J]. Chinese Journal of Dermatology, 2026, 59(3): 286-289. |
| [3] | Yang Wanqing, Chen Nuoran, Meng Xiaoqi, Liu Tingwei, Xu Yang. Application of focused ultrasound in dermatology beyond the anti?aging aspects [J]. Chinese Journal of Dermatology, 2026, 0(3): 20240433-e20240433. |
| [4] | Lei Liangxinwen, Wu Hao, Lu Zhong. Application of optical coherence tomography in cosmetic dermatology [J]. Chinese Journal of Dermatology, 2026, 59(3): 273-277. |
| [5] | Committee on Psoriasis, Chinese Society of Dermatology. Expert consensus on management of psoriasis with comorbidities (2026) [J]. Chinese Journal of Dermatology, 2026, 59(3): 193-207. |
| [6] | Expert Group on the Interpretation of the "Chinese expert consensus on the clinical application of photobiomodulation therapy in dermatology ()", Laser Medicine Group, Chinese Society of Dermatology. Interpretation of the Chinese expert consensus on the clinical application of photobiomodulation therapy in dermatology (2025) [J]. Chinese Journal of Dermatology, 2026, 59(3): 208-212. |
| [7] | Wang Juncheng, Liu Jie. Artificial intelligence in psoriasis: diagnosis, treatment and patient management [J]. Chinese Journal of Dermatology, 2026, 0(3): 20240061-e20240061. |
| [8] | Xu Zhuohong, Zhou Huan, Hu Yu, Gu Heng. Balneotherapy in skin diseases [J]. Chinese Journal of Dermatology, 2026, 0(3): 20250531-e20250531. |
| [9] | Song Hao, Lu Shuyi, Shao Xuebao, Wang Huiting, Chen Yanping, Chen Hao. CRTC1::TRIM11 cutaneous tumors: a report of five cases [J]. Chinese Journal of Dermatology, 2026, 59(2): 127-132. |
| [10] | Chinese Society of Dermatology, China Dermatologist Association, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Rare Skin Diseases Committee, China Alliance for Rare Diseases. Expert consensus on spesolimab in the treatment of inflammatory skin diseases (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(2): 113-119. |
| [11] | Hao Feng, Zuo Mo, Fan Zunqing, Xie Kai, Wang Honglei, Wang Xueqing, Chen Shengli, Chen Xuechao, Liu Guoyan. Clinical study on optical coherence tomography assisting in the diagnosis of basal cell carcinoma [J]. Chinese Journal of Dermatology, 2026, 59(2): 155-160. |
| [12] | Yan Kexin, Zhang Wei, Song Hao, Xu Xiulian. Application of nanomedicine in the diagnosis and treatment of melanoma [J]. Chinese Journal of Dermatology, 2026, 59(2): 189-192. |
| [13] | Chinese Society of Dermatology, China Dermatologist Association. Guidelines on the diagnosis and treatment of dermatitis and eczematous diseases in China (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(2): 97-106. |
| [14] | Chen Hao. Clinical histological characteristics of several novel cutaneous soft tissue neoplasms and their subtypes [J]. Chinese Journal of Dermatology, 2026, 59(2): 120-126. |
| [15] | Huang Renjun, Tong Xing, Wang Ajun, Dong Fenglin, Zhou Naihui, Li Yonggang. Application of high-resolution magnetic resonance imaging and high-frequency ultrasound in the preoperative evaluation of cutaneous melanoma [J]. Chinese Journal of Dermatology, 2026, 59(2): 140-146. |
|